$瑞科生物-B(02_老虎社区_美港股上老虎

左手茅台右手榨菜
2022-09-22

$瑞科生物-B(02179)$对于重组蛋白疫苗来说，新佐剂的确太重要了。不过现在国内疫苗企业真正有突破的还不多，进展较快的只有瑞科生物、依生生物、怡道生物等极个别企业，不过未来能够实现突破的注定也只是少部分企业

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":661880432,"tweetId":"661880432","gmtCreate":1663828256626,"gmtModify":1663828258175,"author":{"id":3548126172544042,"authorId":3548126172544042,"authorIdStr":"3548126172544042","name":"左手茅台右手榨菜","avatar":"https://static.tigerbbs.com/2f2ba9eed79eb242f112e44ac3c80159","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02179\">$瑞科生物-B(02179)$</a>对于重组蛋白疫苗来说，新佐剂的确太重要了。不过现在国内疫苗企业真正有突破的还不多，进展较快的只有瑞科生物、依生生物、怡道生物等极个别企业，不过未来能够实现突破的注定也只是少部分企业</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02179\">$瑞科生物-B(02179)$</a>对于重组蛋白疫苗来说，新佐剂的确太重要了。不过现在国内疫苗企业真正有突破的还不多，进展较快的只有瑞科生物、依生生物、怡道生物等极个别企业，不过未来能够实现突破的注定也只是少部分企业</p></body></html>","text":"$瑞科生物-B(02179)$对于重组蛋白疫苗来说，新佐剂的确太重要了。不过现在国内疫苗企业真正有突破的还不多，进展较快的只有瑞科生物、依生生物、怡道生物等极个别企业，不过未来能够实现突破的注定也只是少部分企业","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/661880432","repostId":0,"isVote":1,"tweetType":1,"viewCount":1378,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02179"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":193,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}